PepGen (PEPG) Earnings Date & Reports

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PEPG is expected to report earnings to fall 12.37% to -80 cents per share on August 07

Q2'25

Est.

$-0.81

Q1'25

Missed

by $0.20

Q4'24

Beat

by $0.13

Q3'24

Beat

by $0.21

Q2'24

Missed

by $0.15

The last earnings report on May 08 showed earnings per share of -92 cents, missing the estimate of -72 cents. With 91.75K shares outstanding, the current market capitalization sits at 49.08M.

View a ticker or compare two or three

Compare

PEPG